Lm. Asmis et al., EPIDERMAL GROWTH-FACTOR STIMULATES CELL-PROLIFERATION AND INHIBITS IODIDE UPTAKE OF FRTL-5 CELLS IN-VITRO, Journal of Endocrinology, 145(3), 1995, pp. 513-520
In accordance with the available data most authors conclude that epide
rmal growth factor (EGF) has very Little or no effect on FRTL-5 cells.
This has been viewed as a serious handicap of this cell line. In the
present study we cultivated three strains of FRTL-5 cells from differe
nt sources and assessed their response to EGF with regard to prolifera
tion, function and differentiation. Cell proliferation was assessed by
counting in a Coulter cell counter after culturing cells at suboptima
l conditions in well plates. Cell function was studied by measuring io
dide uptake. Cell differentiation was examined immunocytochemically by
staining monolayer cultures for thyroglobulin (Tg) and EGF receptor (
EGFr) as well as morphologically by microscopical evaluation of monola
yer cultures. AU three FRTL-5 cell lines investigated express EGFr. In
two wild type FRTL-5 cell lines EGF stimulates growth, an effect that
is enhanced by the presence of TSH, and partially inhibits iodide upt
ake. A third mutated strain of FRTL-5 cells does not respond to EGF. T
g expression can be demonstrated immunocytochemically in EGF-heated ce
lls as well as in controls. Morphologically, in monolayer culture EGF-
treated cells cannot be distinguished from controls. Contrary to previ
ous reports, these studies demonstrate EGF effects on FRTL-5 cells tha
t are consistent with EGF effects established in other thyroid follicu
lar cells.